Matching-adjusted indirect comparison analysis of omalizumab versus dupilumab in patients with chronic spontaneous urticaria. [PDF]
Mosnaim G +4 more
europepmc +1 more source
Phenotyping and unmet need assessment for biological agents in uncontrolled asthma. [PDF]
Tyagi R +7 more
europepmc +1 more source
Association Between Biologic Therapy and Reduced Acute Rhinosinusitis Episodes: A Retrospective Database Study. [PDF]
Zheng W +4 more
europepmc +1 more source
Short-term omalizumab as a potential rescue therapy for alopecia areata flares during Janus kinase inhibitor maintenance. [PDF]
Wang Q +9 more
europepmc +1 more source
Managing Alpha-Gal Allergy in a Case of Bioprosthetic TAVR. [PDF]
Patel R +5 more
europepmc +1 more source
Quantitative CT assessment of structural and functional response to omalizumab in severe allergic asthma: a prospective real-world study. [PDF]
Liu S, Li Y, Wu J, Ye Z, Zhang Y, Ma H.
europepmc +1 more source
Comparison of two omalizumab dose-reduction strategies in patients with chronic spontaneous urticaria during the control phase: standard dose maintenance therapy versus extended interval dose reduction. [PDF]
Zhang L, Chen J.
europepmc +1 more source
Omalizumab in the management of bullous pemphigoid: a six-month retrospective study. [PDF]
Ürün M, Yılmaz ÇE, Ürün YG.
europepmc +1 more source
Chinese Position Paper on Biologic Therapy for Allergic Rhinitis. [PDF]
Zhang Y +37 more
europepmc +1 more source

